EcoDrugPlus

Ensembl ID : ENSMZEG00005023146
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSMZEG00005012341
Gene Symbol: -
Cross references: -
330 Possible Orthologues:

Ensembl ID : ENSMZEG00005000100
Gene Symbol: -
Cross references: -
240 Possible Orthologues:

Ensembl ID : ENSMZEG00005004141
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSMZEG00005025675
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSMZEG00005006616
Gene Symbol: -
1 Cross references
243 Possible Orthologues:

Ensembl ID : ENSMZEG00005023432
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSMZEG00005003842
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSMZEG00005026735
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSMZEG00005009952
Gene Symbol: -
Cross references: -
15 Possible Orthologues:

Ensembl ID : ENSMZEG00005028558
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSMZEG00005014465
Gene Symbol: -
Cross references: -
153 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).